Physician profile
David E Mathis
NPI 1609952217
$1,535.72
in general payments reported to CMS, 2019-2025
19 companies · $75.45 in 2025
The $75.45 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.48 · 2020: $189 · 2021: $272 · 2022: $473 · 2023: $270 · 2024: $169 · 2025: $75.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $335.95 | 2020-2025 | Orbactiv, Kimyrsa, Rezzayo |
| E.R. Squibb & Sons, L.L.C. | $190.44 | 2021-2023 | Camzyos |
| La Jolla Pharmaceutical Company | $165.97 | 2023-2025 | Xerava, Zevtera, Giapreza |
| Janssen Pharmaceuticals, INC | $142.66 | 2021-2024 | Xarelto |
| Pfizer INC. | $135.01 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $132.61 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $87.88 | 2021-2023 | Ultomiris |
| Masimo Corporation | $54.19 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $50.26 | 2022 | |
| Aurinia Pharma U.S., INC. | $42.60 | 2023-2024 | Lupkynis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.18 | 2019-2020 | |
| Amgen INC. | $28.21 | 2023 | Tavneos |
| Gilead Sciences, INC. | $23.25 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $20.08 | 2025 | |
| Mylan Specialty L.P. | $19.77 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.94 | 2021 | |
| Dexcom, INC. | $15.98 | 2023 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $15.15 | 2020 | |
| Exact Sciences Corporation | $14.59 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.